NCT02973776View on ClinicalTrials.gov

Vasoconstriction Trial With LEO 90100 Aerosol Foam

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions

Psoriasis Vulgaris

Interventions

DRUG

LEO 90100 aerosol foam

DRUG

Dermoval®/Dermovate®

DRUG

Diprosone

DRUG

Elocon

DRUG

Locoid

OTHER

LEO 90100 foam vehicle

Trial Locations (1)

06202

CPCAD, Nice

Sponsors

Lead Sponsor

All Listed Sponsors

lead

LEO Pharma

INDUSTRY